Cohance Lifesciences Ltd. Conference Calls and Earnings Call Transcripts

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our Results conference call intimation dated November 02, 2023, that audio recording of the conference call for the quarter and half year ended September 30, 2023 held on Thursday, November 09, 2023, has been uploaded on the Company''s website at https://suvenpharm.com/financial-info/

pdf

Cohance Lifesciences Ltd.

14 Aug 2023, 03:07PM

980.40

-1.61%

Earnings Call

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please find enclosed the transcript of the earnings conference call for the quarter ended Juen 30, 2023.

pdf

Cohance Lifesciences Ltd.

11 Aug 2023

980.40

-1.61%

Earnings Call

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our Results conference call intimation dated August 10, 2023, that audio recording of the conference call for the quarter ended June 30, 2023 held on Thursday, August 10, 2023, has been uploaded on the Company''s website at https://suvenpharm.com/financial-info/ This is for your information and record.

pdf

Cohance Lifesciences Ltd.

10 Aug 2023

980.40

-1.61%

Suven Pharmaceuticals Results Earnings Call for Q1FY24

Conference Call with Suven Pharmaceuticals Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Cohance Lifesciences Ltd.

02 Jun 2023

980.40

-1.61%

Earnings Call

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the earnings conference call for the quarter and year ended March 31, 2023 conducted after the meeting of Board of Directors held on May 25, 2023. The above information has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release This is for your information and record.

pdf

Cohance Lifesciences Ltd.

26 May 2023

980.40

-1.61%

Earnings Call

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with reference to our Results conference call intimation dated May 19, 2023, that audio recording of the conference call for the quarter and year ended March 31, 2023 held on Friday, May 26, 2023, has been uploaded on the Company''s website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-release This is for your information and record.

pdf

Cohance Lifesciences Ltd. Conference Calls and Earnings Call Transcripts